Sen. Collins Strategy To Stabilize Insurance Market Raises Doubts Among Analysts
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
The independent source for health policy research, polling, and news.
641 - 660 of 757 Results
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
In this episode of What the Health? Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
The House and Senate want to reduce or eliminate federal tax credits for orphan drugs used to treat rare diseases, but patients are fighting against the plan.
The legalization of recreational marijuana in California and other states poses an added challenge for drug education programs targeting youths.
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctors office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
A battle brews as Republican Gov. Paul LePage sayshe won't implement the Medicaid expansion unless the Legislature funds Maine's share. Other states, such as Idaho and Utah, are keenly watching.
In Maine and Virginia, health care issues played on voters minds.
About 9 million people claimed about $87 billion in medical deductions in 2015.
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
The bipartisan accord would restore funding for the cost-sharing reductions that President Donald Trump ended last week and would give states more flexibility to devise alternatives for providing and subsidizing health care.
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
Many Californians have been using pot for years, legally and illegally. But newbies, even Grandma, might benefit from a website that contains warnings about the risks.
"If it gets signed by this governor, it's going to send shock waves throughout the country, one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
Congress has yet to take substantive action on this growing consumer concern, but a number of states are flexing their cost-control muscle.
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
The measure proposed by Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) would disrupt the existing health system more than any of the measures considered so far this year, according to supporters and critics.
Republicans are making a concerted push to unite around a bill sponsored by Sens. Lindsey Graham and Bill Cassidy that would gut major provisions of the federal health law.
穢 2026 KFF